OTONOMY INC (OTIC) Stock Price, Quote, News and Overview
NASDAQ:OTIC - Nasdaq - US68906L1052 - Common Stock - Currency: USD
OTIC Quote, Performance and Key Statistics
0.077
-0.01 (-11.19%)
The current stock price of OTIC is 0.077 USD. In the past month the price decreased by -29.87%. In the past year, price decreased by -96.65%.
OTIC Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.44 | 390.99B | ||
| JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
| MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
| PFE | PFIZER INC | 8.46 | 149.04B | ||
| SNY | SANOFI-ADR | 13.58 | 136.54B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
| GSK | GSK PLC-SPON ADR | 7.78 | 74.77B | ||
| ZTS | ZOETIS INC | 27.1 | 72.39B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
Related stock screener links
About OTIC
Company Profile
Otonomy, Inc. operates as a biopharmaceutical company. The company is headquartered in San Diego, California and currently employs 51 full-time employees. The company went IPO on 2014-08-13. The firm is focused on the development of therapeutics for neurotology. The firm pipeline includes OTIPRIO, OTIVIDEX, OTO-313, and OTO-413. OTIPRIO is a single-dose, physician-administered antibacterial for the treatment of pediatric patients with bilateral otitis media with effusion undergoing TTP surgery for the treatment of patients with acute otitis externa (AOE). OTIVIDEX is a sustained-exposure formulation of the steroid dexamethasone in development for the treatment of Menieres disease. OTO-313 is a sustained-exposure formulation of gacyclidine, a potent and selective N-Methyl-D-Aspartate (NMDA) receptor antagonist, in in Phase II for tinnitus. OTO-413 is a sustained-exposure formulation of brain-derived neurotrophic factor (BDNF) in Phase IIa development for the repair of cochlear synaptopathy, an underlying pathology in age-related and noise-induced hearing loss. OTO-825, a gene therapy for congenital hearing loss.
Company Info
OTONOMY INC
5626 Oberlin Drive, Suite 100
San Diego CALIFORNIA 92121 US
CEO: David A. Weber
Employees: 51
Company Website: http://www.otonomy.com/
Phone: 18587687823.0
OTONOMY INC / OTIC FAQ
What is the stock price of OTONOMY INC today?
The current stock price of OTIC is 0.077 USD. The price decreased by -11.19% in the last trading session.
What is the ticker symbol for OTONOMY INC stock?
The exchange symbol of OTONOMY INC is OTIC and it is listed on the Nasdaq exchange.
On which exchange is OTIC stock listed?
OTIC stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for OTONOMY INC stock?
9 analysts have analysed OTIC and the average price target is 9.18 USD. This implies a price increase of 11822.08% is expected in the next year compared to the current price of 0.077. Check the OTONOMY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is OTONOMY INC worth?
OTONOMY INC (OTIC) has a market capitalization of 4.40M USD. This makes OTIC a Nano Cap stock.
How many employees does OTONOMY INC have?
OTONOMY INC (OTIC) currently has 51 employees.
Is OTONOMY INC (OTIC) expected to grow?
The Revenue of OTONOMY INC (OTIC) is expected to decline by -100% in the next year. Check the estimates tab for more information on the OTIC EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy OTONOMY INC (OTIC) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of OTIC, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of OTIC, evaluating the profitability, health, valuation and growth aspects
- OTONOMY INC (OTIC) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- OTONOMY INC (OTIC) Sales and EPS estimates to see what analysts future expectations are.
- OTONOMY INC (OTIC) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- OTONOMY INC (OTIC) Insider and Institutional Ownership to learn about the owners and their transactions.
- OTONOMY INC (OTIC) Stock Chart to make your own analysis
- OTONOMY INC (OTIC) Latest news and press-releases to stay up to date.
Does OTONOMY INC (OTIC) stock pay dividends?
OTIC does not pay a dividend.
When does OTONOMY INC (OTIC) report earnings?
OTONOMY INC (OTIC) will report earnings on 2023-02-27.
What is the Price/Earnings (PE) ratio of OTONOMY INC (OTIC)?
OTONOMY INC (OTIC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
OTIC Technical Analysis
OTIC Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to OTIC. OTIC has a bad profitability rating. Also its financial health evaluation is rather negative.
OTIC Financial Highlights
Over the last trailing twelve months OTIC reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS increased by 4.94% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |
OTIC Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 78% to OTIC. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 3.04% and a revenue growth -100% for OTIC